Abstract
Surgery has been frequently used to obtain locoregional control and has played a major role in esophageal cancer treatment. Curative resection of the primary lesion needs the removal of the gross lesion itself as well as any possible concomitant spread of the carcinoma. Thoracic esophageal carcinoma is often accompanied by extensive metastasis to the lymph nodes in the cervical, thoracic, and abdominal regions. Because sufficient dissection of the mediastinal lymph nodes is necessary, right thoracotomy and lymph node dissection plus total extirpation of the thoracoabdominal esophagus are generally performed. Transthoracic esophagectomy is one of the most invasive surgeries. The rate of morbidity and mortality for esophagectomy has been decreasing, but still remains high. Substantial advances in preoperative risk evaluation, improved operative techniques, and perioperative management are demanding. In future perspectives, to improve the rate of cure and the quality of life after surgery, more attention should be paid to minimal invasive esophagectomy and the individualization of treatment. Thoracoscopy-assisted esophagectomy including robot-assisted esophagectomy has been reported as promising surgical procedures, in views of its minimal invasiveness, better cosmetics, lesser pain, reduced postoperative respiratory complication, radical curability, and favorable long-term outcomes. If the oncological benefit is proved by the prospective studies, these procedures could become the standard procedures for transthoracic esophagectomy. Sentinel lymph node mapping acquires individual information to allow for adjustments and modifications to surgical procedures for patients. This process might be a procedure that could play a significant role in eliminating the necessity for the uniform application of highly invasive surgery.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bedenne L, Michel P, Bouche O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25:1160–8.
Suntharalingam M. Definitive chemoradiation in the management of locally advanced esophageal cancer. Semin Radiat Oncol. 2007;17:22–8.
Udagawa H, Akiyama H, et al. Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique. Dis Esophagus. 2001;14:110–4.
Jamal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
Vizcaino AP, Moreno V, Lambert R, et al. Time trends incidence of both major histologic types of esophageal carcinoma in selected countries, 1973-1995. Int J Cancer. 2002;99:860–8.
Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–73.
Ando N, Ozawa S, Kitagawa Y, et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 2000;232:225–32.
Kato H, Watanabe H, Tachimori Y, et al. Evaluation of the neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg. 1991;51:931–5.
Nishihira T, Hirayama K, Mori S. A prospective randomized control trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg. 1998;175:47–51.
Altorki N, Kent M, Ferrara RN, et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236:177–83.
Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for oesophageal cancer. Comparison of three-field lymphadenctomy with two- field lymphadenctomy. Ann Surg. 1995;222:654–62.
Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg. 2004;240:962–72.
Tsurumaru M, Kajiyama Y, Udagawa H, et al. Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovas Surg. 2001;7:325–9.
Orringer MB. Editorial on “occult cervical nodal metastases in esophgageal cancer: preliminary results of three-field lymphadenectomy”. J Thorac Cardiovas Surg. 1997;113:538–9.
Japanese Society for Esophageal Diseases. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6:1–25.
Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patietnts included in Japanese nationwide web-based database. Ann Surg. 2014;260(2):259–66.
Metzer R, Bollschweiler E, Vallbohmer D, et al. High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus. 2004;17(4):310–4.
Rodgers M, Jobe BA, O’Rourke RW, et al. Case volume as a predictor of inpatient mortality after esophagectomy. Arch Durg. 2007;142(9):829–39.
Japanese Research Society for Esophageal Diseases. The report of treatment results of esophageal carcinoma in Japan (1979, 1980, 1982, 1982) (in Japanese). 10th ed. Tokyo: National Cancer Center; 2000a.
Japanese Research Society for Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan (1988~1994) 1st edn. Chiba: Japanese Society for Esophageal Diseases; 2000b.
Tachimori Y, Ozawa S, Fujishiro M, et al. Comprehensive registry of esophageal cancer in Japan, 2006. Esophagus. 2010;23(2):145–52.
Fujita H, Ozawa S, Kuwano H, et al. Esophagectomy for cancer: clinical concerns support centralizing operations within the larger hospitals. Dis Esophagus. 2014;11:21–47.
Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78(5):1783–9.
Ferri LE, Law S, Wong KH, et al. The influence of technical complications on postoperative outcome and survival after esophagectomy. Ann Surg Oncol. 2006;13:557–64.
Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662–9.
Biere SS, van Berg Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer; a multicenter, open-label, randomized controlled trial. Lancet. 2012;379:1887–92.
Murthy SC, Law S, Whooley BP, et al. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovas Surg. 2003;126:1162–7.
Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg. 2003;75(1):217–22.
Martin RE, Letsos P, Taves DH. Oropharyngeal dysphagia in esophageal cancer before and after transhiatal esophagectomy. Dysphagia. 2001;16(1):23–31.
Raymond D. Complication of esophagectomy. Sug Clin North Am. 2012;92:1299–313.
Berry MF, Atkins BZ, Tong BC, et al. A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia. J Thorac Cardiovas Surg. 2010;140:1266–71.
Dumont P, Wihlm JM, Hentz JG, et al. Respiratory complications after surgical treatment of esophageal cancer. A study of 309 patients according to the type of resection. Eur J Cardiothorac Surg. 1995;9:539–43.
Baba M, Natsugoe S, Shimada M, et al. Dose hoarseness of voice from recurrent nerve paralysis after esophagectomy for carcinoma influence patient quality of life? J Am Coll Surg. 1999;188:231–6.
Nishimaki T, Suzuki T, Tnanaka Y, et al. Evalutating the rational extent of dissection in radical esophagectomy for invasive carcinoma of the thoracic esophagus. Surg Today. 1997;27:3–8.
Paracchia A, Ruol A. Bardini R, et al lymph node dissection for cancer of the thoracic esophagus: how extended should it be? Analysis of personal data and review of the literature. Dis Esophagus. 1992;5:69.
Kitajima M, Kitagawa Y. Surgical treatment of esophageal cancer – the advent of the era of individualization. N Engl J Med. 2002;347(21):1705–9.
Blichik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol. 2001;19:1128–36.
Krag D, Weaver D, Ashikage T, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med. 1998;339:941–6.
Morton DL, Thompson JF, Essner R, et al. Multicenter selective lymphadenectomy trial group. Validation of accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann Surg. 1999;230:453–63.
Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.
Kitagawa Y, Fujii H, Mukai M, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am. 2000;80:1799–809.
Kitagawa Y, Fujii H, Mukai M, et al. Intraoperative lymphatic mapping and sentinel lymph node sampling in esophageal and gastric cancer. Surg Oncol Clin N Am. 2002;11:293–304.
Takeuchi H, Fujii H, Ando N, et al. Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg. 2009;249:757–63.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kawakubo, H. (2020). Surgery Transthoracic Esophagectomy. In: Ando, N. (eds) Esophageal Squamous Cell Carcinoma. Springer, Singapore. https://doi.org/10.1007/978-981-15-4190-2_10
Download citation
DOI: https://doi.org/10.1007/978-981-15-4190-2_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4189-6
Online ISBN: 978-981-15-4190-2
eBook Packages: MedicineMedicine (R0)